Top 20 Pharma Ranks: As Some Move Up, Others Fall Down
Top 20 Pharma Ranks: As Some Move Up, Others Fall Down
$131.00
Although the ranking of Scrip’s top 100 pharma companies remained largely the same as the previous year, there were some surprising moves up – and down – in rank for major players within pharma. Find out who in the top 20 moved, and in what direction, in this essential resource from In Vivo.
Author: Jessica Merrill
Publisher: InVivo
- Description
In Vivo uses Scrip’s ranking of Top 100 pharma companies (based on sales figures for 2017) to report on the companies in the top 20 of the list. Get an inside look at the rankings, which saw Shire PLC move up to join the top 20 for the first time on the eve of their takeover by Takeda. See what other companies moved up (and which dropped in rank), and what criteria was used to rate them. You’ll see the effect that R&D spend had on overall rankings, and get a glimpse into how this year’s rankings might presage future
© Informa UK Ltd. This document is a licensed product and is not to be reproduced or redistributed
Do you have a subscription to Datamonitor Healthcare, Biomedtracker or Meddevicetracker? You may already have access to these reports, contact your account manager or email pharma@informabi.com for further help or assistance.
Swiss Regulatory Change Takes Over 500 OTCs Out Of Pharmacy 
Sign up to the